TABLE 1.

Characteristics of M. szulgai study isolates and associated patients

Patient no.VAMC accession no.Specimen sourceHospital unit(s)Date of positive culture (mo/day/yr)Risk factor(s)aRAPD-PCR gel patternb16S rRNA geno group clusterPigment
100TB0087Sputum3A01/16/00MSOF, CACNDcBuff
200TB0146Sputum4A01/27/00CACIBuff
300TB0180Sputum4A, 3C02/02/00CHF, PECIBuff
400TB0296Sputum4A02/19/00CACIBuff
500TB0479Urine4A03/26/00CMLCIBuff
600TB0524Urine3A04/04/00DMCIBuff
700TB0525Sputum3A04/04/00RACIBuff
800TB0556Sputum3A04/08/00COPDCIBuff
900TB0999-2Sputum3B06/25/00MAC, CLLCIBuff
1000TB1093Bronchial wash3B07/10/00SCCACNDBuff
1100TB1375Sputum3A08/25/00DM, COPDCNDBuff
1200TB1423Sputum3B09/02/00NoneCIBuff
1300TB1448-2Stool3B09/09/00HIVCIBuff
1400TB1517Urine4A09/18/00MSOFCIBuff
1500TB1538Bronchial wash3C09/20/00CACNDBuff
1600TB1571Sputum4A, 5K09/24/00CACIBuff
1700TB1594Bronchial wash3B, 3D09/27/00SCICIBuff
1800TB1744Sputum1A10/25/00SCICIBuff
1900TB1796Sputum3A11/06/00NoneCIBuff
2098TB2561Sputum3A12/25/98COPDCIBuff
2199TB0239Sputum4D02/05/99Treated TBCIBuff
2299TB0446Sputum4A03/04/99COPDCIBuff
2399TB0950Sputum3B05/28/99ESRDCIBuff
2499TB1239-1Sputum4D07/20/99CVACIBuff
2599TB1327Sputum3B08/03/99CACIBuff
2699TB1390Sputum4A08/12/99HIVCIBuff
2799TB1544Sputum3A09/19/99CACIBuff
2899TB1592Sputum3A09/29/99HIVCIBuff
2999TB1866Sputum4A11/12/99CACNDBuff
3099TB1918Sputum4A11/19/99HIVCIBuff
3199TB2036-2Sputum3A12/09/99HIVCIBuff
3200TB0011Sputum4B01/05/00MyelofibrosisA-3IYellow
3600TB1638SputumOutpatient10/04/00COPDBIYellow
3799TB1239-2Sputum4D07/20/99CVAA-2IIYellow
3500TB1577Sputum3B09/25/00TBA-2IIYellow
3400TB1448-1Stool3B09/09/00HIVNDIIYellow
3300TB0544SputumOutpatient04/06/00HIVNDNDYellow
38NoneHospital water (main tank)12/12/00CIBuff
  • a Abbreviations: MSOF, multisystem organ failure; CA, carcinoma; CHF, congestive heart failure; PE, pleural effusion; CML, chronic myelogenous leukemia; DM, diabetes mellitus; RA, rheumatoid arthritis; COPD, chronic obstructive pulmonary disease; MAC, Mycobacterium avium complex; CLL, chronic lymphocytic leukemia; SCCA, squamous cell carcinoma; HIV, human immunodeficiency virus; SCI, spinal cord injury; TB, tuberculosis; ESRD, end-stage renal disease; CVA, cerebrovascular accident.

  • b RAPD-PCR gel patterns refer to the results shown in Fig. 2 as follows: pigmented M. szulgai strain patterns A-2 (lanes 6 to 9), A-3 (lane 10), and B (lane 11); pseudoepidemic strain pattern C (lanes 12 to 20).

  • c ND, not done.